Market revenue in 2023 | USD 20.0 million |
Market revenue in 2030 | USD 50.6 million |
Growth rate | 14.2% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Product |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Merck KGaA, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, GenScript ProBio, Beam Therapeutics Inc, Intellia Therapeutics Inc, Cellectis SA, Creative Bioarray |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to base editing market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 65% in 2023. Horizon Databook has segmented the UK base editing market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UK base editing market , including forecasts for subscribers. This country databook contains high-level insights into UK base editing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account